Sequential cetuximab/bevacizumab therapy is associated with improved outcomes in patients with wild‐type KRAS exon 2 metastatic colorectal cancer

PURPOSE: Combination of biological therapy and chemotherapy improves the survival of patients with metastatic colorectal cancer (mCRC). However, the optimal biological therapy sequence remains unclear. In this retrospective study, we evaluated the clinical outcomes of patients with mCRC treated with...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Cancer Med
Main Authors: Hsu, Hung‐Chih, Liu, Yu‐Chun, Wang, Chuang‐Wei, Chou, Wen-Chi, Hsu, Yu-Jen, Chiang, Jy-Ming, Lin, Yung-Chang, Yang, Tsai-Sheng
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley and Sons Inc. 2019
Assuntos:
Clinical Cancer Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6601597/
https://ncbi.nlm.nih.gov/pubmed/31090176
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cam4.2235
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados